← Open Payments lookup

ABBY MELANCON: Open Payments

NPI 1902534035 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$639 in 26 payments from 9 companies in 2025. Trend: 2023 $135 · 2024 $309 · 2025 $639

Food & beverage: $639
CompanyPaymentsAmount
Janssen Biotech, Inc.8$264
Genentech USA, Inc.5$101
Incyte Corporation3$76
Celgene Corporation3$58
Merck Sharp & Dohme LLC2$40
Karyopharm Therapeutics Inc.2$31
Legend Biotech USA Inc.1$25
Takeda Pharmaceuticals U.S.A., Inc.1$24
Invivyd Inc1$19

Products named: TECVAYLI, RYBREVANT, Venclexta, BREYANZI, JAKAFI, PREVYMIS, Polivy, XPOVIO.

Industry payments across MS — which companies pay providers there.